PPARG and thyroid cancer, nonmedullary, 2: Few studies have investigated whether activating mutation in RAS genes, previously associated with pathogenesis of follicular tumors [20-22], may cooperate with PAX8/PPARγ rearrangement in the pathogenesis of FTC.